EMTT Treatment

Extracorporeal Magnetotransduction Therapy (EMTT) is a non-invasive treatment that uses high energy magnetic pulses to trigger the regeration of tendons, muscles, bones, and nervous tissues that are often difficult to reach.

How Does EMTT Work?

EMTT works by emmiting extremly high magnetic pulses at oscillate frequencies ranging from 100–300 kHz. The magnetic pulses stimulates a cellular response in the targeted area that promotes your bodys natural healing proccess.

EMTT offers patients a risk free solution to treating overuse conditions, sports injuries, and chronic conditions that cause pain and inflimmation.

EMTT Intended Uses

Musculoskeletal Disorders

Musculoskeletal Disorders

Acute and Chronic Pain

Acute and Chronic Pain



EMTT Intended Uses

FDA Approved

"Verification and validation testing was performed and demonstrated that the MAGNETOLITHR(Extracorporeal Magnetotransduction Therapy device) meets the design specifications and is safe and effective for its intended use."
- U.S. Food & Drug Administration


How often will I need to get treated with EMTT

EMTT provides relief for many patients after 4 – 8 sessions. Treatments are usually spaced out in 1 week intervals, but for acute conditions 2-3 treatments per week may be appropriate.

Are there side effects?

There are no reported side effects of EMTT®, however it is a physical treatment so the patient may experience mild discomfort and reddening of the skin

How effective is shockwave therapy?

New results from a double-blind, randomized and placebo-controlled study on Extracorporeal Magnetotransduction Therapy (EMTT) found that EMTT is an effective non-invasive therapy and non-pharmacological treatment option for patients suffering from degenerative joint diseases and enthesopathie.

The study included 43 patients who, for more than 12 weeks, had suffered from significant and clinically relevant shoulder pain due to tendinopathies.

The patients were randomly split into a 2 groups, one group would recove the treatment, the other would recive a placebo. After 8 sessions of EMTT group 1 (the treatment group) had expericened significant reductions in pain compared to group 2 (the placebo group).
Source: L. Gerdesmeyer, K. Knobloch, H. Gollwitzer, M. Ringeisen, Prospective double blinded placebo controlled trial of high energetic magneto transduction therapy in shoulder joint enthesiopathies, Sports Orthopaedics and Traumatology, Volume 39, Issue 2, 2023, Page 212, ISSN 0949-328X,


Is it covered by insurance?

Many insurance policies consider this type of treatment as elective or non-essential, and as a result, EMTT is typically not covered by insurance plans.